-+ 0.00%
-+ 0.00%
-+ 0.00%

Stephens & Co. Downgrades Catalyst Pharmaceuticals to Equal-Weight

Benzinga·05/07/2026 13:40:01
Listen to the news
Stephens & Co. analyst Sudan Loganathan downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) from Overweight to Equal-Weight.